CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism
Science Signaling · 2024
DOI: 10.1126/scisignal.adl5100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Vincent Rondeau und 27 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Mitochondria, Signal Transduction, Receptors, CXCR4. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Both cell-intrinsic and niche-derived, cell-extrinsic cues drive the specification of hematopoietic multipotent progenitors (MPPs) in the bone marrow, which comprise multipotent MPP1 cells and lineage-restricted MPP2, MPP3, and MPP4 subsets. Patients with WHIM syndrome, a rare congenital immunodeficiency caused by mutations that prevent desensitization of the chemokine receptor CXCR4, have an excess of myeloid cells in the bone marrow. Here, we investigated the effects of increased CXCR4 signaling on the localization and fate of MPPs. Knock-in mice bearing a WHIM syndrome–associated CXCR4 mutation ( CXCR4 1013 ) phenocopied the myeloid skewing of bone marrow in patients. Whereas MPP4 cells in wild-type mice differentiated into lymphoid cells, MPP4s in CXCR4 1013 knock-in mice differentiated into myeloid cells. This myeloid rewiring of MPP4s in CXCR4 1013 knock-in mice was associated with enhanced signaling mediated by the kinase mTOR and increased oxidative phosphorylation (OXPHOS). MPP4s also localized further from arterioles in the bone marrow of knock-in mice compared with wild-type mice, suggesting that the loss of extrinsic cues from the perivascular niche may also contribute to their myeloid skewing. Chronic treatment with the CXCR4 antagonist AMD3100 or the mTOR inhibitor rapamycin restored the lymphoid potential of MPP4s in knock-in mice. Thus, CXCR4 desensitization drives the lymphoid potential of MPP4 cells by dampening the mTOR-dependent metabolic changes that promote myeloid differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.
- OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.
- Direction à la Recherche Clinique et à l'Innovation, Centre Hospitalier de Versailles, Le Chesnay, France.
- Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
- INSERM U1279, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France.
- Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France.
ORCID-Profile: Vincent Rondeau, Lilian Roland, Amélie Bonaud, Mélanie Khamyath, Bérénice Schell, Marc Delord, Ghislain Bidaut, Séverine Lecourt, Christelle Freitas, Nathalie Mazure, David H McDermott, Niclas Setterblad, Nicolas Dulphy, Françoise Bachelerie, Michel Aurrand-Lions, Daniel Stockholm, Camille Lobry, Philip M Murphy, Karl Balabanian
Förderung
- Intramural NIH HHS
Zitieren
APA
Rondeau, V., Kalogeraki, M., Roland, L., Nader, Z. A., Gourhand, V., Bonaud, A., Lemos, J., Khamyath, M., Moulin, C., Schell, B., Delord, M., Bidaut, G., Lecourt, S., Freitas, C., Anginot, A., Mazure, N., McDermott, D. H., Parietti, V., Setterblad, N., …, & Balabanian, K. (2024). CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism. Science Signaling. https://doi.org/10.1126/scisignal.adl5100
Vancouver
Rondeau V, Kalogeraki M, Roland L, Nader ZA, Gourhand V, Bonaud A, et al. CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism. Science Signaling. 2024. doi:10.1126/scisignal.adl5100
BibTeX
@article{Rondeau2024,
author = {Rondeau, Vincent and Kalogeraki, Maria and Roland, Lilian and Nader, Zeina Abou and Gourhand, Vanessa and Bonaud, Amélie and Lemos, Julia and Khamyath, Mélanie and Moulin, Clémentine and Schell, Bérénice and Delord, Marc and Bidaut, Ghislain and Lecourt, Séverine and Freitas, Christelle and Anginot, Adrienne and Mazure, Nathalie and McDermott, David H and Parietti, Véronique and Setterblad, Niclas and Dulphy, Nicolas and Bachelerie, Françoise and Aurrand-Lions, Michel and Stockholm, Daniel and Lobry, Camille and Murphy, Philip M and Espéli, Marion and Mancini, Stéphane J C and Balabanian, Karl},
title = {CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism},
journal = {Science Signaling},
year = {2024},
doi = {10.1126/scisignal.adl5100}
}
EUVIMED